WeMed is an interventional diagnosis and treatment solutions provider.
Funding reportedLast round: Series D
What company datasets say WeMed raised
Funding, as reported
Reported in all400Min the source's currency
Rounds4
Last roundSeries D
Last round dateApr 2021
Investors listed11
Clinical Trials in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put WeMed in front of investors. Or tell us what we have wrong.